Virus inactivation at moderately low pH varies with virus and buffer properties

Pratik U Joshi1,2, Christa L Meingast2,3, Xuankuo Xu4

  • 1Department of Chemical Engineering, Michigan Technological University, Houghton, Michigan, USA.

Biotechnology Journal
|December 7, 2021
PubMed
Abstract

Insights

Pseudorabies virus (SuHV) and herpes simplex virus-1 (HSV-1) show different inactivation rates in low pH buffers, impacting their use as interchangeable models in therapeutic protein manufacturing. Equine arteritis virus (EAV) remained infectious.

Area of Science:

  • Biotechnology
  • Virology
  • Process Chemistry

Background:

  • Virus inactivation is crucial for therapeutic protein manufacturing.
  • Low pH buffers are standard for enveloped virus clearance.
  • Model virus selection impacts viral clearance study outcomes.

Purpose of the Study:

  • Compare inactivation susceptibility of Pseudorabies virus (SuHV), herpes simplex virus-1 (HSV-1), and equine arteritis virus (EAV) at low pH.
  • Evaluate the efficacy of glycine, acetate, and citrate buffers.
  • Determine the impact of buffer strength on virus inactivation.

Main Methods:

  • Tested SuHV, HSV-1, and EAV inactivation at pH 4.0 and 4°C.
  • Utilized glycine, acetate, and citrate buffers at varying strengths.
  • Assessed viral infectivity post-treatment.

Main Results:

  • Inactivation susceptibility order: SuHV > HSV > EAV.
  • Buffer effectiveness order: citrate > acetate > glycine.
  • Equine arteritis virus (EAV) showed stability and infectivity across all tested conditions.

Conclusions:

  • Pseudorabies virus (SuHV) and herpes simplex virus-1 (HSV-1) exhibit differential inactivation, precluding their interchangeable use as virus models.
  • Smaller enveloped viruses like EAV may retain infectivity under moderately low pH conditions.